Prion Diseases


Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are transmissible degenerative disorders of the central nervous system in mammals. TSEs are fatal and are caused by the proteinaceous infectious particles, termed prions that lack informational nucleic acids. TSEs include Creutzfeldt–Jakob disease in humans, scrapie in sheep, bovine spongiform encephalopathy or ‘mad cow disease’ in cattle and chronic wasting disease in deer and elk. These diseases manifest spongiform degeneration, reactive gliosis, and deposition of prion aggregates in the brain. The aetiology of TSEs is sporadic, genetic, or acquired. The primary structure of PrPC, conformational diversity of PrPSc, and their interplay influence intra‐ and inter‐species prion transmission. The role of lymphoreticular system is pivotal in early prion pathogenesis and neuroinvasion, whereas neuronal damage caused by prion infection could be achieved by several different mechanisms. Despite the potential risk for public health, diagnosis and therapy for prion diseases are currently unavailable.

Key Concepts:

  • Prion diseases represent a group of human and animal diseases that include sporadic, inherited, and acquired Creutzfeldt–Jakob disease (CJD), Gerstmann–Sträussler–Scheinker syndrome (GSS), and fatal familial insomnia (FFI) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep, chronic wasting disease (CWD) in cervids, transmissible mink encephalopathy (TME) in mink, feline spongiform encephalopathy (FSE) in cats, and exotic ungluate encephalopathy (EUE) in exotic ungulates.

  • Prion diseases are fatal neurological disorders and caused by the unconventional proteinaceous pathogen, termed prion.

  • Prion diseases manifest characteristic clinical and neuropathological features.

  • Prion diseases are transmissible within and between the species.

  • Transmission of prion diseases is determined by the amino acid sequence variability of PrPC and prion strains conferred by conformational diversity of PrPSc.

  • The lymphoreticular system is crucial in prion pathogenesis and neuroinvasion.

  • Gain of pathologic PrPSc function and/or loss of neuroprotective PrPC function facilitate neuronal damages in the central nervous system by direct or indirect mechanism associated with astrocyte and microglial cells.

  • Atypical TSEs and human‐to‐human transmission of vCJD have been identified.

  • Diagnosis and therapy for prion disease are not available.

Keywords: prion; PrPSc; PrPC; TSE; CJD; Scrapie; BSE; CWD; TME; atypical TSE

Figure 1.

Characteristic neuropathological features of transmissible spongiform encephalopathies. (a) Haematoxylin and eosin (H&E) staining of the cerebral cortex of a patient with Creutzfeldt–Jakob disease displaying the characteristic spongiform, vacuole‐like morphology. (b) H&E staining of the cerebral cortex of a healthy individual. Provided by P. Nelson (University of Kentucky). (c) Activation and proliferation of reactive, swollen astrocytes is visualised in the grey matter of the brain of a patient with Creutzfeldt–Jakob disease by staining with antibodies against glial fibrillary acidic protein (brown colour). (d) Immunohistochemical staining of the gray matter of the brain of a patient with Creutzfeldt–Jakob disease using anti‐PrP antibodies representing prion protein deposits (brown colour). (e, f) Florid plaques in the cerebral cortex of a patient with variant Creutzfeldt–Jakob disease detected by H&E staining (e) and immunohistochemistry (f). I. Cali, W. Zou, and P. Gambetti (National Prion Disease Pathology Surveillance Center, Case Western Reserve University) provided the immunohistochemical image in panel (f).

Figure 2.

Possible models for prion neuroinvasion. In (a), B lymphocytes, which may be genotypically PrP‐positive or PrP‐negative, physically transport prions to their sites of replication in the spleen. These sites may be represented, in part or entirely, by follicular dendritic cells (FDCs). Direct neuroinvasion then occurs preferentially along fibres of the (PNS), which may support the transfer of prions to the central nervous system (CNS), depending on their own expression of PrPC. In (b) a second possibility is illustrated: B cells are not directly involved in neuroinvasion. In this instance, the crucial role of B cells in neuroinvasive scrapie relies on their function in inducing maturation of FDCs.

Figure 3.

BSE and vCJD cases. (a) BSE cases reported in the United Kingdom. (b) BSE cases worldwide excluding the United Kingdom. (c) vCJD cases reported in the United Kingdom. (d) Cumulative vCJD cases in individual countries. Statistical data were obtained from the World Organisation for Animal Health (OIE, for BSE and National CJD Surveillance Unit for the United Kingdom ( for vCJD. The data of 2010 represent the number of BSE and vCJD cases as of September 2010 and June 2010, respectively. According to the U.S. case report, the third patient of the U.S. was born and raised in Saudi Arabia and has lived permanently in the U.S. since late 2005. The patient was most likely infected as a child when living in Saudi Arabia. The patient from Japan had resided in the UK during the period 1980–1996.



Aguzzi A and Heikenwalder M (2005) Prions, cytokines, and chemokines: a meeting in lymphoid organs. Immunity 22: 145–154.

Andrews NJ, Farrington CP, Ward HJT et al. (2003) Deaths from variant Creutzfeldt–Jakob disease in the UK. Lancet 361: 751–752.

Banks WA, Niehoff ML, Adessi C et al. (2004) Passage of murine scrapie prion protein across the mouse vascular blood‐brain barrier. Biochemical and Biophysical Research Communications 318: 125–130.

Benestad SL, Thu B, Bratberg B et al. (2003) Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Veterinary Record 153: 202–208.

Biacabe AG, Laplanche JL, Ryder S et al. (2004) Distinct molecular phenotypes in bovine prion diseases. EMBO Reports 5: 110–115.

Biacabe AG, Morignat E, Vulin J et al. (2008) Atypical bovine spongiform encephalopathies, France, 2001–2007. Emerging Infectious Diseases 14: 298–300.

Brown P, Preece M, Brandel JP et al. (2000) Iatrogenic Creutzfeldt–Jakob disease at the millennium. Neurology 55: 1075–1081.

Bruce ME (2003) TSE strain variation: An investigation into prion disease diversity. British Medical Bulletin 66: 99–108.

Bucciantini M, Giannoni E, Chiti F et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507–511.

Budka H (2003) Neuropathology of prion diseases. British Medical Bulletin 66: 121–130.

Bueler H, Aguzzi A, Sailer A et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1347.

Carlson GA, Kingsbury DT, Goodman PA et al. (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46: 503–511.

Casalone C, Zanusso G, Acutis P et al. (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: Molecular similarities with sporadic Creutzfeldt–Jakob disease. Proceedings of the National Academy of Sciences of the United States of America 101: 3065–3070.

Chiarini LB, Freitas AR, Zanata SM et al. (2002) Cellular prion protein transduces neuroprotective signals. EMBO Journal 21: 3317–3326.

Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annual Review of Neuroscience 24: 519–550.

Collinge J, Beck J, Campbell T et al. (1996) Prion protein gene analysis in new variant cases of Creutzfeldt–Jakob disease. Lancet 348: 56.

Collinge J, Whitfield J, McKintosh E et al. (2006) Kuru in the 21st century – an acquired human prion disease with very long incubation periods. Lancet 367: 2068–2074.

Creutzfeldt HG (1920) Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Zeitschrift für die gesamte Neurologie und Psychiatrie 57: 1–18.

Dickinson AG, Meikle VMH and Fraser H (1968) Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. Journal of Comparative Pathology 78: 293–299.

Fischer M, Rulicke T, Raeber A et al. (1996) Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO Journal 15: 1255–1264.

Gajdusek DC and Zigas V (1957) Degenerative disease of the central nervous system in New Guinea? The endemic occurrence of “kuru” in the native population. New England Journal of Medicine 257: 974–978.

Hamir AN, Kunkle RA, Cutlip RC et al. (2006) Transmission of chronic wasting disease of mule deer to Suffolk sheep following intracerebral inoculation. Journal of Veterinary Diagnostic Investigation 18: 558–565.

Hetz C, Russelakis‐Carneiro M, Maundrell K et al. (2003) Caspase‐12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO Journal 22: 5435–5445.

Hill AF, Desbruslais M, Joiner S et al. (1997) The same prion strain causes vCJD and BSE. Nature 389: 448–450.

Jakob A (1921) Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde (spastische Pseudosklerose‐Encephalomyelopathie mit disseminierten Degenerationsherden). Zeitschrift für die gesamte Neurologie und Psychiatrie 64: 147–228.

Jeffrey M and González L (2007) Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathology and Applied Neurobiology 33: 373–394.

Klein MA, Frigg R, Flechsig E et al. (1997) A crucial role for B cells in neuroinvasive scrapie. Nature 390: 687–691.

Klein MA, Frigg R, Raeber AJ et al. (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Medicine 4: 1429–1433.

Llewelyn CA, Hewitt PE, Knight RS et al. (2004) Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 363: 417–421.

Marella M, Gaggioli C, Batoz M et al. (2005) Pathological prion protein exposure switches on neuronal mitogen‐activated protein kinase pathway resulting in microglia recruitment. Journal of Biological Chemistry 280: 1529–1534.

Marsh RF, Bessen RA, Lehmann S et al. (1991) Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy. Journal of General Virology 72: 589–594.

Marsh RF and Hadlow WJ (1992) Transmissible mink encephalopathy. Revue Scientifique et Technique 11: 539–550.

Masters CL, Gajdusek DC and Gibbs CJ Jr (1981) Creutzfeldt–Jakob disease virus isolations from the Gerstmann–Straussler syndrome. Brain 104: 559–588.

Miller M and Williams E (2003) Prion disease: horizontal prion transmission in mule deer. Nature 425: 35–36.

Montrasio F, Frigg R, Glatzel M et al. (2000) Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288: 1257–1259.

Peden AH, Head MW, Ritchie DL et al. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527–529.

Peden AH, McCardle L, Head MW et al. (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16: 296–304.

Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144.

Prusiner SB (1998) Prions. Proceedings of the National Academy of Sciences of the United States of America 95: 13363–13383.

Prusiner SB (2001) Shattuck Lecture: Neurodegenerative diseases and prions. New England Journal of Medicine 344: 1516–1526.

Race R, Oldstone M and Chesebro B (2000) Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. Journal of Virology 74: 828–833.

Saborio GP, Permanne B and Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810–813.

Telling GC, Haga T, Torchia M et al. (1996a) Interactions between wild‐type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes and Development 10: 1736–1750.

Telling GC, Parchi P, DeArmond SJ et al. (1996b) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079–2082.

Terry LA, Jenkins R, Thorne L et al. (2007) First case of H‐type bovine spongiform encephalopathy identified in Great Britain. Veterinary Record 160: 873–874.

Trevitt CR and Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129: 2241–2265.

Wells GAH, Scott AC, Johnson CT et al. (1987) A novel progressive spongiform encephalopathy in cattle. Veterinary Record 121: 419–420.

Westergard L, Christensen HM and Harris DA (2007) The cellular prion protein (PrPC): its physiological function and role in disease. Biochimica et Biophysica Acta 1772: 629–644.

Will RG, Ironside JW, Zeidler M et al. (1996) A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347: 921–925.

Williams ES and Miller MW (2002) Chronic wasting disease in deer and elk in North America. Revue Scientifique et Technique 21: 305–316.

Wroe SJ, Pal S, Siddique D et al. (2006) Clinical presentation and pre‐mortem diagnosis of variant Creutzfeldt–Jakob disease associated with blood transfusion: a case report. Lancet 368: 2061–2067.

Further Reading

Aguzzi A, Baumann F and Bremer J (2008) The prion's elusive reason for being. Annual Review of Neuroscience 31: 439–477.

Aguzzi A, Sigurdson C and Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annual Review of Pathology: Mechanisms of Disease 3: 11–40.

Belay ED and Schonberger LB (2005) The public health impact of prion diseases. Annual Review of Public Health 26: 191–212.

Caughey B, Baron GS, Chesebro B et al. (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annual Review of Biochemistry 78: 177–204.

Chien P, Weissman JS and DePace AH (2004) Emerging principles of conformation‐based prion inheritance. Annual Review of Biochemistry 73: 617–656.

Cohen FE and Prusiner SB (1998) Pathologic conformations of prion proteins. Annual Review of Biochemistry 67: 793–819.

Hornlimann B, Riesner D and Kretzschmarr H (2006) Prions in Humans and Animals. Berlin, Germany: Walter de Gruyter.

Prusiner SB (2004) Prion Biology and Diseases, 2nd edn. Cold Spring Harbor Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.

Prusiner SB and Scott MR (1997) Genetics of prions. Annual Review of Genetics 31: 139–175.

Uptain SM and Lindquist S (2002) Prions as protein‐based genetic elements. Annual Review of Microbiology 56: 703–741.

Weissmann C and Aguzzi A (2005) Approaches to therapy of prion diseases. Annual Review of Medicine 56: 321–344.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Ryou, Chongsuk(May 2011) Prion Diseases. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1002/9780470015902.a0000428.pub2]